Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Alig SK"'
Autor:
Alig SK; Department of Internal Medicine III, Ludwig Maximilian University (LMU) Hospital, Munich, Germany., Chapuy B; Department of Hematology, Oncology and Cancer Immunology, Charité-University Medical Center Berlin, Berlin, Germany., Ennishi D; Center for Comprehensive Genomic Medicine, Okayama University Hospital, Okayama, Japan., Dunleavy K; Department of Hematology, Lombardi Comprehensive Cancer Center, Washington, DC, USA., Hodson DJ; Cambridge Stem Cell Institute and Department of Haematology, University of Cambridge, Cambridge, UK.
Publikováno v:
Histopathology [Histopathology] 2024 Nov 15. Date of Electronic Publication: 2024 Nov 15.
Autor:
Alig SK; Ludwig Maximilian University Hospital.
Publikováno v:
Blood [Blood] 2024 Oct 10; Vol. 144 (15), pp. 1550-1552.
Autor:
Khouja M; Second Medical Department, University Hospital Schleswig-Holstein, Kiel, Germany., Jiang L; Institute for Medical Information Processing, Biometry and Epidemiology (IBE), Faculty of Medicine, LMU Munich, Munich, Germany., Pal K; Second Medical Department, University Hospital Schleswig-Holstein, Kiel, Germany.; Center of Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czech Republic., Stewart PJ; The Patrick G Johnston Centre for Cancer Research, Queens University Belfast, Belfast, UK., Regmi B; Second Medical Department, University Hospital Schleswig-Holstein, Kiel, Germany.; Department of Pneumology and Intensive Care Medicine, University Hospital RWTH Aachen, Aachen, Germany., Schwarz M; Second Medical Department, University Hospital Schleswig-Holstein, Kiel, Germany., Klapper W; Department of Pathology, Hematopathology Section and Lymph Node Registry, University Hospital Schleswig-Holstein, Kiel, Germany., Alig SK; Department of Medicine III, University Hospital, Ludwig-Maximilian-University, Munich, Germany., Darzentas N; Second Medical Department, University Hospital Schleswig-Holstein, Kiel, Germany., Kluin-Nelemans HC; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Hermine O; Department of Hematology, Hôpital Necker, Assistance Publique Hôpitaux de Paris, University Paris Descartes, Paris, France.; INSERM U1163 and CNRS 8254, Imagine Institute, Université Sorbonne Paris Cité, Paris, France., Dreyling M; Department of Medicine III, University Hospital, Ludwig-Maximilian-University, Munich, Germany., Gonzalez de Castro D; The Patrick G Johnston Centre for Cancer Research, Queens University Belfast, Belfast, UK., Hoster E; Institute for Medical Information Processing, Biometry and Epidemiology (IBE), Faculty of Medicine, LMU Munich, Munich, Germany., Pott C; Second Medical Department, University Hospital Schleswig-Holstein, Kiel, Germany. c.pott@med2.uni-kiel.de.
Publikováno v:
Leukemia [Leukemia] 2024 Sep 16. Date of Electronic Publication: 2024 Sep 16.
Autor:
Shukla ND; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA., Schroers-Martin JG; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA., Sworder BJ; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA., Kathuria KR; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA., Alig SK; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA., Frank MJ; Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University, Stanford, CA., Miklos DB; Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University, Stanford, CA., Coutre S; Division of Hematology, Department of Medicine, Stanford University, Stanford, CA., Diehn M; Department of Radiation Oncology, Stanford University, Stanford, CA., Khodadoust MS; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA., Roschewski M; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD., Kurtz DM; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA., Alizadeh AA; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA.; Division of Hematology, Department of Medicine, Stanford University, Stanford, CA.; Stanford Cancer Institute, Stanford University, Stanford, CA.; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA.
Publikováno v:
Blood advances [Blood Adv] 2024 Feb 13; Vol. 8 (3), pp. 780-784.
Autor:
Lauer EM; Department of Medicine I, Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Riegler E; Department of Medicine I, Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Mutter JA; Department of Medicine I, Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Divisions of Oncology and Hematology, Department of Medicine, Stanford University, Stanford, CA, USA., Alig SK, Bleul S; Department of Medicine I, Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Kuehn J; Department of Medicine I, Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Ranganathan L; Department of Medicine I, Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Klingler C; Department of Medicine I, Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Demerath T; Department of Neuroradiology, Medical Center, University of Freiburg, Freiburg, Germany., Würtemberger U; Department of Neuroradiology, Medical Center, University of Freiburg, Freiburg, Germany., Rau A; Department of Neuroradiology, Medical Center, University of Freiburg, Freiburg, Germany.; Department of Radiology, Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Weiß J; Department of Radiology, Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Eisenblaetter M; Department of Radiology, Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Bamberg F; Department of Radiology, Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Prinz M; Institute of Neuropathology, Medical Faculty, University of Freiburg, Freiburg, Germany.; Center for Basics in NeuroModulation (NeuroModulBasics), Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany., Finke J; Department of Medicine I, Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Duyster J; Department of Medicine I, Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Illerhaus G; Department of Hematology/Oncology and Palliative Care, Klinikum Stuttgart, Stuttgart, Germany., Diehn M; Department of Radiation Oncology, Stanford School of Medicine, Stanford, CA, USA., Alizadeh AA; Divisions of Oncology and Hematology, Department of Medicine, Stanford University, Stanford, CA, USA., Schorb E; Department of Medicine I, Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Reinacher PC; Department of Stereotactic and Functional Neurosurgery, Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Fraunhofer Institute for Laser Technology (ILT), Aachen, Germany., Scherer F; Department of Medicine I, Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK) Partner Cite Freiburg and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Publikováno v:
Neuro-oncology [Neuro Oncol] 2024 Feb 02; Vol. 26 (2), pp. 374-386.
Autor:
Alig SK; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA., Shahrokh Esfahani M; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA., Garofalo A; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA., Li MY; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada., Rossi C; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA.; Hematology Department, University Hospital F. Mitterrand and Inserm UMR 1231, Dijon, France., Flerlage T; Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, TN, USA., Flerlage JE; Department of Oncology, St Jude Children's Research Hospital, Memphis, TN, USA., Adams R; Department of Pediatrics, Division of Pediatric Hematology and Oncology, Stanford University, Stanford, CA, USA., Binkley MS; Department of Radiation Oncology, Stanford University Medical Center, Stanford, CA, USA., Shukla N; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA., Jin MC; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA., Olsen M; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA., Telenius A; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada., Mutter JA; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA., Schroers-Martin JG; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA., Sworder BJ; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA., Rai S; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada., King DA; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA., Schultz A; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA., Bögeholz J; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA., Su S; Department of Radiation Oncology, Stanford University Medical Center, Stanford, CA, USA., Kathuria KR; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA., Liu CL; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA., Kang X; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA., Strohband MJ; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA., Langfitt D; Department of Bone Marrow Transplant and Cellular Therapy, St Jude Children's Research Hospital, Memphis, TN, USA., Pobre-Piza KF; Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, TN, USA., Surman S; Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, TN, USA., Tian F; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA., Spina V; Laboratory of Molecular Diagnostics, Department of Medical Genetics EOLAB, Bellinzona, Switzerland., Tousseyn T; Department of Imaging and Pathology, KU Leuven, Leuven, Belgium., Buedts L; Department of Human Genetics, KU Leuven, Leuven, Belgium., Hoppe R; Department of Radiation Oncology, Stanford University Medical Center, Stanford, CA, USA., Natkunam Y; Department of Pathology, Stanford University, Stanford, CA, USA., Fornecker LM; Institut de Cancérologie Strasbourg Europe (ICANS) and University of Strasbourg, Strasbourg, France., Castellino SM; Department of Pediatrics, Emory University, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, USA., Advani R; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA., Rossi D; Clinic of Hematology, Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.; Laboratory of Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland.; Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland., Lynch R; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Ghesquières H; Department of Hematology, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre Benite, France., Casasnovas O; Hematology Department, University Hospital F. Mitterrand and Inserm UMR 1231, Dijon, France., Kurtz DM; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA., Marks LJ; Department of Pediatrics, Division of Pediatric Hematology and Oncology, Stanford University, Stanford, CA, USA., Link MP; Department of Pediatrics, Division of Pediatric Hematology and Oncology, Stanford University, Stanford, CA, USA., André M; Department of Haematology, Université Catholique de Louvain, CHU UCL Namur, Yvoir, Belgium., Vandenberghe P; Department of Human Genetics, KU Leuven, Leuven, Belgium.; Department of Hematology, University Hospitals Leuven, Leuven, Belgium., Steidl C; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada., Diehn M; Department of Radiation Oncology, Stanford University Medical Center, Stanford, CA, USA. diehn@stanford.edu., Alizadeh AA; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA. arasha@stanford.edu.
Publikováno v:
Nature [Nature] 2024 Jan; Vol. 625 (7996), pp. 778-787. Date of Electronic Publication: 2023 Dec 11.
Autor:
Cherng HJ; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.; Division of Hematology and Oncology, Columbia University Irving Medical Center, New York, NY., Alig SK; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA., Oki Y; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Nastoupil LJ; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Fayad L; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Neelapu SS; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Turturro F; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Hagemeister F; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Craig AFM; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA., Macaulay CW; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA., Rodriguez MA; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Lee HJ; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., McDonnell TJ; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Flowers CR; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Vega F; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Green MR; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX., Feng L; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX., Kurtz DM; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA., Alizadeh AA; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA., Davis RE; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Westin JR; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.
Publikováno v:
Blood advances [Blood Adv] 2023 Apr 11; Vol. 7 (7), pp. 1137-1145.
Autor:
Mutter JA; Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; University of Freiburg, Faculty of Biology, Freiburg, Germany., Alig SK; Divisions of Oncology and Hematology, Department of Medicine, Stanford University, Stanford, CA., Esfahani MS; Divisions of Oncology and Hematology, Department of Medicine, Stanford University, Stanford, CA., Lauer EM; Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Mitschke J; Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Kurtz DM; Divisions of Oncology and Hematology, Department of Medicine, Stanford University, Stanford, CA., Kühn J; Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Bleul S; Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Olsen M; Divisions of Oncology and Hematology, Department of Medicine, Stanford University, Stanford, CA., Liu CL; Divisions of Oncology and Hematology, Department of Medicine, Stanford University, Stanford, CA., Jin MC; Divisions of Oncology and Hematology, Department of Medicine, Stanford University, Stanford, CA., Macaulay CW; Divisions of Oncology and Hematology, Department of Medicine, Stanford University, Stanford, CA., Neidert N; Department of Neurosurgery, Medical Center-University of Freiburg, Freiburg, Germany.; Berta-Ottenstein-Programme for Clinician Scientists Medical Center, University of Freiburg, Freiburg, Germany., Volk T; Department of Neurology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Eisenblaetter M; Department of Radiology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Rauer S; Department of Neurology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Heiland DH; Department of Neurosurgery, Medical Center-University of Freiburg, Freiburg, Germany., Finke J; Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Duyster J; Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Wehrle J; Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Prinz M; Institute of Neuropathology, Medical Faculty, University of Freiburg, Freiburg, Germany.; Center for Basics in NeuroModulation (NeuroModulBasics), Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany., Illerhaus G; Department of Hematology/Oncology and Palliative Care, Klinikum Stuttgart, Stuttgart, Germany., Reinacher PC; Department of Stereotactic and Functional Neurosurgery, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Fraunhofer Institute for Laser Technology (ILT), Aachen, Germany., Schorb E; Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Diehn M; Department of Radiation Oncology, Stanford School of Medicine, Stanford, CA., Alizadeh AA; Divisions of Oncology and Hematology, Department of Medicine, Stanford University, Stanford, CA., Scherer F; Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK) partner site Freiburg and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Mar 20; Vol. 41 (9), pp. 1684-1694. Date of Electronic Publication: 2022 Dec 21.
Autor:
Sworder BJ; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA., Kurtz DM; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA; Stanford Cancer Institute, Stanford University, Stanford, CA 94305, USA., Alig SK; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA., Frank MJ; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA 94305, USA; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford, CA 94305, USA., Shukla N; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA., Garofalo A; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA., Macaulay CW; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA., Shahrokh Esfahani M; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA., Olsen MN; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA., Hamilton J; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA., Hosoya H; Division of Hematology, Department of Medicine, Stanford University, Stanford, CA 94305, USA., Hamilton M; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA 94305, USA., Spiegel JY; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA 94305, USA; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford, CA 94305, USA., Baird JH; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA 94305, USA; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford, CA 94305, USA., Sugio T; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA., Carleton M; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA., Craig AFM; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA., Younes SF; Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA., Sahaf B; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA 94305, USA; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford, CA 94305, USA., Sheybani ND; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA., Schroers-Martin JG; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA; Division of Hematology, Department of Medicine, Stanford University, Stanford, CA 94305, USA., Liu CL; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA., Oak JS; Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA., Jin MC; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA., Beygi S; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA., Hüttmann A; Department of Hematology, University Hospital of Essen, Essen, Germany., Hanoun C; Department of Hematology, University Hospital of Essen, Essen, Germany., Dührsen U; Department of Hematology, University Hospital of Essen, Essen, Germany., Westin JR; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Khodadoust MS; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA; Stanford Cancer Institute, Stanford University, Stanford, CA 94305, USA., Natkunam Y; Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA., Majzner RG; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford, CA 94305, USA; Division of Hematology/Oncology, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA 94305, USA., Mackall CL; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford, CA 94305, USA; Division of Hematology/Oncology, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA 94305, USA; Parker Institute for Cancer Immunotherapy, Stanford University School of Medicine, Stanford, CA 94305, USA., Diehn M; Stanford Cancer Institute, Stanford University, Stanford, CA 94305, USA; Department of Radiation Oncology, Stanford University, Stanford, CA 94305, USA; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA 94305, USA., Miklos DB; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA 94305, USA; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford, CA 94305, USA., Alizadeh AA; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA; Stanford Cancer Institute, Stanford University, Stanford, CA 94305, USA; Division of Hematology, Department of Medicine, Stanford University, Stanford, CA 94305, USA; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA 94305, USA. Electronic address: arasha@stanford.edu.
Publikováno v:
Cancer cell [Cancer Cell] 2023 Jan 09; Vol. 41 (1), pp. 210-225.e5. Date of Electronic Publication: 2022 Dec 29.
Autor:
Esfahani MS; Divisions of Oncology and of Hematology, Department of Medicine, Stanford School of Medicine, Stanford, CA, USA.; Department of Radiation Oncology, Stanford School of Medicine, Stanford, CA, USA.; Stanford Cancer Institute, Stanford School of Medicine, Stanford, CA, USA., Hamilton EG; Program in Cancer Biology, Stanford School of Medicine, Stanford, CA, USA., Mehrmohamadi M; Divisions of Oncology and of Hematology, Department of Medicine, Stanford School of Medicine, Stanford, CA, USA.; Department of Radiation Oncology, Stanford School of Medicine, Stanford, CA, USA., Nabet BY; Department of Radiation Oncology, Stanford School of Medicine, Stanford, CA, USA.; Stanford Cancer Institute, Stanford School of Medicine, Stanford, CA, USA., Alig SK; Divisions of Oncology and of Hematology, Department of Medicine, Stanford School of Medicine, Stanford, CA, USA., King DA; Divisions of Oncology and of Hematology, Department of Medicine, Stanford School of Medicine, Stanford, CA, USA., Steen CB; Divisions of Oncology and of Hematology, Department of Medicine, Stanford School of Medicine, Stanford, CA, USA.; Institute for Stem Cell Biology and Regenerative Medicine, Stanford School of Medicine, Stanford, CA, USA.; Department of Biomedical Informatics, Stanford School of Medicine, Stanford, CA, USA., Macaulay CW; Divisions of Oncology and of Hematology, Department of Medicine, Stanford School of Medicine, Stanford, CA, USA., Schultz A; Stanford Cancer Institute, Stanford School of Medicine, Stanford, CA, USA., Nesselbush MC; Program in Cancer Biology, Stanford School of Medicine, Stanford, CA, USA., Soo J; Divisions of Oncology and of Hematology, Department of Medicine, Stanford School of Medicine, Stanford, CA, USA., Schroers-Martin JG; Divisions of Oncology and of Hematology, Department of Medicine, Stanford School of Medicine, Stanford, CA, USA.; Stanford Cancer Institute, Stanford School of Medicine, Stanford, CA, USA., Chen B; Divisions of Oncology and of Hematology, Department of Medicine, Stanford School of Medicine, Stanford, CA, USA., Binkley MS; Department of Radiation Oncology, Stanford School of Medicine, Stanford, CA, USA., Stehr H; Stanford Cancer Institute, Stanford School of Medicine, Stanford, CA, USA., Chabon JJ; Department of Radiation Oncology, Stanford School of Medicine, Stanford, CA, USA., Sworder BJ; Divisions of Oncology and of Hematology, Department of Medicine, Stanford School of Medicine, Stanford, CA, USA., Hui AB; Department of Radiation Oncology, Stanford School of Medicine, Stanford, CA, USA., Frank MJ; Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford School of Medicine, Stanford, CA, USA., Moding EJ; Department of Radiation Oncology, Stanford School of Medicine, Stanford, CA, USA., Liu CL; Divisions of Oncology and of Hematology, Department of Medicine, Stanford School of Medicine, Stanford, CA, USA., Newman AM; Institute for Stem Cell Biology and Regenerative Medicine, Stanford School of Medicine, Stanford, CA, USA.; Department of Biomedical Informatics, Stanford School of Medicine, Stanford, CA, USA., Isbell JM; Thoracic Surgery Service, Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine, New York, NY, USA., Rudin CM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Li BT; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Kurtz DM; Divisions of Oncology and of Hematology, Department of Medicine, Stanford School of Medicine, Stanford, CA, USA.; Stanford Cancer Institute, Stanford School of Medicine, Stanford, CA, USA., Diehn M; Department of Radiation Oncology, Stanford School of Medicine, Stanford, CA, USA. diehn@stanford.edu.; Stanford Cancer Institute, Stanford School of Medicine, Stanford, CA, USA. diehn@stanford.edu.; Institute for Stem Cell Biology and Regenerative Medicine, Stanford School of Medicine, Stanford, CA, USA. diehn@stanford.edu., Alizadeh AA; Divisions of Oncology and of Hematology, Department of Medicine, Stanford School of Medicine, Stanford, CA, USA. arasha@stanford.edu.; Stanford Cancer Institute, Stanford School of Medicine, Stanford, CA, USA. arasha@stanford.edu.; Institute for Stem Cell Biology and Regenerative Medicine, Stanford School of Medicine, Stanford, CA, USA. arasha@stanford.edu.
Publikováno v:
Nature biotechnology [Nat Biotechnol] 2022 Apr; Vol. 40 (4), pp. 585-597. Date of Electronic Publication: 2022 Mar 31.